With 510(k) clearance, platform streamlines OR and clinical access to imaging data
Sony Electronics' NUCLeUS(tm) Courtesy: Sony Electronics
By Whitney J. Palmer
Sony Electronics announced Wednesday that it received 510(k) clearance from the U.S. Food and Drug Administration for its NUCLeUS™ Operating Room, Imaging Management and Collaboration platform.
NUCLeUS is an open, vendor neutral video-over-IP platform that connects devices, applications, and data to facilitate surgical workflow. It connects to the PACS, hospital information system, operating room planning system, and DICOM worklists to, potentially, improve efficiency.
According to a company press release, NUCLeUS uses an existing network infrastructure to support up to 4K resolution and is designed to enhance and streamline workflow for operating rooms and clinical environments by providing direct imaging data access through a central dashboard. Via the system, providers can also capture and manage video and audio content in real-time.
“We are eager to put NUCLeUS in the hands of doctors, nurses, and OR managers in the [United States] so they can experience first-hand how the platform can dramatically improve surgical collaboration and potentially contribute to better outcomes,” said Theresa Alesso, president of Sony Electronics’ Pro divison in a press statement. “With the ongoing development of unique ‘smart applications,’ NUCLeUS will continue to push the boundaries of what is possible in the [operating room.]”
The system is already in use in more than 500 operating room venues in hospitals throughout Europe, including the United Kingdom, Belgium, and Sweden. Sales within the United States will begin immediately, according to the company.
Based on company information, important characteristics of NUCLeUS include:
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.